Closing the Treatment Gap: Integrating Alcohol Use Services & Medications for Alcohol Use Disorder into Primary Care - November 2024

Closing the Treatment Gap: Integrating Alcohol Use Services & Medications for Alcohol Use Disorder into Primary Care

Developed in Collaboration with Providers Clinical Support System - Medications for Alcohol Use Disorder

Host: Montana Primary Care Association (MPCA)

Wednesday, November 6, 2024
Thursday, November 7, 2024

Live Session: Hilton Garden Inn, Bozeman, MT

Overview

This two-day training hosted by the Providers Clinical Support System – Medications for Alcohol Use Disorder (PCSS-MAUD) will provide a comprehensive overview of alcohol use disorder (AUD), AUD treatment and recovery options, including medications for alcohol use disorder and cultural considerations for treating different populations. The training will build skills to identify and diagnose AUD, determine a medication to treat AUD based on patients’ unique needs and goals, and assess the risk for alcohol withdrawal syndrome. Through didactic presentations, case discussions, knowledge checks, and small group discussions, training participants will have the opportunity to apply learned skills and engage with their peers and the presenters.  

Training topics include medications for alcohol use disorder; ambulatory management of AUD and alcohol withdrawal syndrome; treating AUD in different healthcare settings including primary care/FQHCs, hospitals, emergency departments; treating AUD in special populations including pregnant/post-partum individuals, Indigenous and American Indians, adolescents and youth, and older adults. 

Training will take place at the Hilton Garden Inn in Bozeman, MT. The training will start at 1 PM MT on Wednesday, November 6, and 9 AM on Thursday, November 7.  

This activity is eligible for 8 CE credits. The target audience for this Introductory level session includes pharmacists, physicians, counselors, social workers, physician assistants/associates, nurse practitioners, and nurses.  

In support of improving patient care, ASAM is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Learning Objectives

Upon completion, learners will be able to:

1. Describe the three FDA-approved medications for alcohol use disorder and how best to determine a medication regimen. 
   
2. Identify at least two strategies for addressing barriers to integrating alcohol use disorder services into primary care settings. 
3. Demonstrate how to assess risk for alcohol withdrawal syndrome and determine a treatment plan based on risk.

Registration

This education is made available for free to all learners through grant funding by the Substance Abuse and Mental Health Services Administration (SAMHSA). Funding for this initiative was made possible (in part) by grant number 1H79TI086771-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Cancellations

All cancellation requests must be made in writing to pcss@ASAM.org within 90 days of registration. Automatic cancellations and notifications will be made for any course with a live-activity component that has been cancelled.

Open Registration: 09/13/2024 - 11/06/2024

Close Access Date: 11/06/2027